In addition, Mady et al. [8] assessed its antitumor potential and showed that meleagrin bears antiproliferative, antimigratory and anti-invasive properties in vitro against a wide panel of c-Met-dependent breast cancer cells. The gene discussed is MET; the disease is breast carcinoma.